RHS Financial’s Pediatrix Medical MD Stock Holding History

RHS Financial’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$292K	Buy	+11,333	New	+$299K	0.1%	136

Other funds holding MD

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

RHS Financial's MD Position: Q3 2026 in Review

RHS Financial opened a new position in Pediatrix Medical (MD) in Q3 2026: 11,333 shares worth $292K. The stake represents 0.1% of the portfolio and ranks #136 among its holdings.

16 funds tracked by Wall St. Rank hold MD as of Q3 2026.

RHS Financial held 11,333 shares of Pediatrix Medical worth $292K as of Q3 2026.
Pediatrix Medical was a new RHS Financial position in Q3 2026.
Pediatrix Medical made up 0.1% of RHS Financial's portfolio in Q3 2026, its #136 holding.
16 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on RHS Financial's 13F filing for Q3 2026, filed 13 Oct 2026.